Samuli Ripatti

Samuli Ripatti is a Professor of Biometry in the Department of Public Health at the University of Helsinki's Faculty of Medicine. He serves as Director of the Institute for Molecular Medicine Finland (FIMM) since 2023 and leads the Academy of Finland's Center of Excellence in Complex Disease Genetics. His research integrates genetics, statistics, and clinical medicine to advance understanding of cardiometabolic diseases and genomic risk prediction.

Education:

• Statistics major, University of Helsinki
• PhD in Mathematical Statistics, Stockholm University (2002)
• Docent in Statistics, University of Helsinki (2007)

Research interests focus on cardiometabolic diseases, polygenic risk scores (PRS), and genetic epidemiology. He has pioneered PRS for disease prevention and developed clinical risk algorithms, with applications in precision medicine and global health initiatives.

Recent publications highlight trends in polygenic risk modeling across diverse diseases, lipidomics, sleep disorders, and trauma outcomes. His work spans genomics, bioinformatics, and translational medicine.

Scientific awards:

• Knight, First Class, of the Order of the White Rose of Finland (2021)
• Highly Cited Researcher (2018, 2017, 2016)

Ripatti chairs doctoral programs in life sciences and the EU-funded INTERVENE project, which develops genomic risk prediction methods. He has led research groups at FIMM-EMBL, the Broad Institute, and the Wellcome Trust Sanger Institute.

As Director of FIMM and member of scientific advisory boards (e.g., NMRC Singapore, EXCEED), he shapes global genomic research collaborations and biobank infrastructure.